about
Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B CellsInterferon-alpha triggers B cell effector 1 (Be1) commitmentProlonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus.The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs).Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial.Transient depletion of B cells in young mice results in activation of regulatory T cells that inhibit development of autoimmune disease in adultsLipopolysaccharide Attenuates CD40 Ligand-Induced Regulatory B10 Cell Expansion and IL-10 Production in Mouse Splenocytes.Innate pathways to B-cell activation and tolerance.Maintenance of the plasma cell pool is independent of memory B cells.Cytokine-producing B lymphocytes-key regulators of immunity.Phenotypic and functional heterogeneity of human memory B cells.B cells and immunological tolerance.Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets.Follicular B cells in thyroids of mice with spontaneous autoimmune thyroiditis contribute to disease pathogenesis and are targets of anti-CD20 antibody therapy.Rituximab: a review of dermatological applications.B cell immunology for the clinician.Hepatitis C virus infection and mixed cryoglobulinemiaGWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis.B cell biology: implications for treatment of systemic lupus erythematosus.Mechanisms by Which B Cells and Regulatory T Cells Influence Development of Murine Organ-Specific Autoimmune DiseasesSelective inhibitors of phosphoinositide 3-kinase delta: modulators of B-cell function with potential for treating autoimmune inflammatory diseases and B-cell malignancies.Comparative assessment of clinical response in patients with rheumatoid arthritis between PF-05280586, a proposed rituximab biosimilar, and rituximabBeyond Antibodies: B Cells and the OPG/RANK-RANKL Pathway in Health, Non-HIV Disease and HIV-Induced Bone Loss.Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis.In vitro effects of rituximab on the proliferation, activation and differentiation of human B cells.B cell immunosenescence: different features of naive and memory B cells in elderly.Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease.Cholecystokinin octapeptide regulates lipopolysaccharide-activated B cells co-stimulatory molecule expression and cytokines production in vitro.
P2860
Q30279164-8F3B06CF-4B3E-4056-A2E9-C23ADA76DAEDQ33895026-F29CFD54-8D80-4BEC-9FDC-4DE3AD5AEA84Q34063315-B5C917F4-B8F6-4353-8BA6-79EE5C82B851Q34373452-AB512B60-B0B7-45DB-A8C3-9329FA4B3E7FQ35030581-4CA33154-DF48-4676-B9F9-4734C896D3BAQ35852020-A3CBB53E-A9A7-4E2C-BB70-B66DC61AE185Q35896923-D1049FB2-30F2-4FC7-9271-F60802DEA35CQ36172913-69E2D718-947C-481A-9CF1-902D9EBBB053Q36534521-E54A041F-F20D-4707-8306-99C0D2C35324Q36775913-53029CE2-7821-4E39-A6A3-DB2E0D2DB3CDQ37079426-9C270F55-9508-4CD5-B814-44AACC04C5A5Q37308252-02F5130F-DA3E-4BCB-8A45-0E6C910EF7DEQ37436035-56ED47DC-C990-4454-93DC-1E1FB6FB8E0AQ37512037-2678A516-7AC9-42B9-B545-BFBCF66D5C9EQ37781697-CDCDB753-D1F9-4811-9E20-FAC48C0EF0AEQ37829609-4922D4EB-BB4C-42A4-AD87-336C6C92836BQ38030533-16A75BC4-7225-467C-AEF8-8ECDF37B8D79Q38093041-4238B2C2-ACD8-451A-8717-1E87B89525AEQ38095860-BAE750CA-4AD4-40F8-9E36-635FBE7B793DQ39109245-6ED9DB00-BCC1-4342-A6EE-5E6A64CDBF00Q42320922-E887EE68-0BE0-424A-A06F-F884C3D737A2Q42372516-BD280833-0564-45E6-A4BE-1CA5C820BC6AQ47194100-02CD6EA5-BD03-4A57-BFC6-D67F9915BBBDQ50980453-BCF1F053-57DB-4CFC-9546-C59E26DC62A2Q50983859-FED4248B-B52F-49BE-BFFD-7E7A05D987C4Q50994551-23FF9E0B-5F05-4414-B8BC-8BA882D7250EQ51967521-74173CD4-A1A0-4A90-96B2-0FF83874399CQ54384623-76D8AF49-5C8C-4E65-A44A-60133BD6B257
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
B cell depletion therapy in autoimmune diseases.
@ast
B cell depletion therapy in autoimmune diseases.
@en
type
label
B cell depletion therapy in autoimmune diseases.
@ast
B cell depletion therapy in autoimmune diseases.
@en
prefLabel
B cell depletion therapy in autoimmune diseases.
@ast
B cell depletion therapy in autoimmune diseases.
@en
P2093
P356
P1476
B cell depletion therapy in autoimmune diseases.
@en
P2093
Iñaki Sanz
Jennifer H Anolik
R John Looney
P304
P356
10.2741/2254
P577
2007-01-01T00:00:00Z